236 related articles for article (PubMed ID: 23543219)
1. Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes.
Hochberg M; Gilead L; Markel G; Nemlich Y; Feiler Y; Enk CD; Denichenko P; Karni R; Ingber A
Arch Dermatol Res; 2013 Aug; 305(6):519-28. PubMed ID: 23543219
[TBL] [Abstract][Full Text] [Related]
2. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma.
Chen YB; Liao XY; Zhang JB; Wang F; Qin HD; Zhang L; Shugart YY; Zeng YX; Jia WH
Int J Oncol; 2017 Feb; 50(2):622-630. PubMed ID: 28035363
[TBL] [Abstract][Full Text] [Related]
3. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
[TBL] [Abstract][Full Text] [Related]
4. A-to-I RNA editing of the IGFBP7 transcript increases during aging in porcine brain tissues.
Larsen K; Kristensen KK; Momeni J; Farajzadeh L; Bendixen C
Biochem Biophys Res Commun; 2016 Oct; 479(3):596-601. PubMed ID: 27687550
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-binding protein 7 regulates keratinocyte proliferation, differentiation and apoptosis.
Nousbeck J; Sarig O; Avidan N; Indelman M; Bergman R; Ramon M; Enk CD; Sprecher E
J Invest Dermatol; 2010 Feb; 130(2):378-87. PubMed ID: 19710688
[TBL] [Abstract][Full Text] [Related]
6. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
7. NAV3 copy number changes and target genes in basal and squamous cell cancers.
Maliniemi P; Carlsson E; Kaukola A; Ovaska K; Niiranen K; Saksela O; Jeskanen L; Hautaniemi S; Ranki A
Exp Dermatol; 2011 Nov; 20(11):926-31. PubMed ID: 21995814
[TBL] [Abstract][Full Text] [Related]
8. Expression of RUNX3 in skin cancers.
Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
10. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
12. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation.
Chen Y; Cui T; Knösel T; Yang L; Zöller K; Petersen I
Lung Cancer; 2011 Jul; 73(1):38-44. PubMed ID: 21095038
[TBL] [Abstract][Full Text] [Related]
13. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
[TBL] [Abstract][Full Text] [Related]
14. The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas.
Basyuk E; Coulon V; Le Digarcher A; Coisy-Quivy M; Moles JP; Gandarillas A; Journot L
Mol Cancer Res; 2005 Sep; 3(9):483-92. PubMed ID: 16179495
[TBL] [Abstract][Full Text] [Related]
15. IGFBP7's susceptibility to proteolysis is altered by A-to-I RNA editing of its transcript.
Godfried Sie C; Hesler S; Maas S; Kuchka M
FEBS Lett; 2012 Jul; 586(16):2313-7. PubMed ID: 22750143
[TBL] [Abstract][Full Text] [Related]
16. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer.
Delehedde M; Cho SH; Sarkiss M; Brisbay S; Davies M; El-Naggar AK; McDonnell TJ
Cancer; 1999 Apr; 85(7):1514-22. PubMed ID: 10193941
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid receptor isoform mRNA expression differs between BCC and SCC of the skin.
Hartmann F; Kosmidis M; Mühleisen B; French LE; Hofbauer GF
Arch Dermatol; 2010 Jun; 146(6):675-6. PubMed ID: 20566936
[No Abstract] [Full Text] [Related]
19. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 protein in benign and malignant epidermal pathologic conditions.
Helander SD; Peters MS; Pittelkow MR
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):741-8. PubMed ID: 8227547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
